GlaxoSmithKline said on Tuesday it had chosen its head of consumer healthcare, Emma Walmsley, as its new chief executive, after several months reviewing internal and external candidates.
She will become the first woman to head a t
GlaxoSmithKline is to adopt a graduated approach to patenting its medicines, depending on the wealth of different countries, in order to make drugs more affordable in the developing world.
China has fined GlaxoSmithKline (GSK) a record three billion yuan ($489 million) for paying bribes to doctors to use its drugs, underlining the risks of doing business in the country while also ending a damaging chapter for the British drugmaker
GlaxoSmithKline is recalling all supplies of its non-prescription weight-loss drug Alli in the US and Puerto Rico after customers reported finding other pills and tablets in some bottles.
The news is a fresh blow for a product onc
GlaxoSmithKline has stopped worldwide deliveries of two chickenpox vaccines for children after discovering that some batches produced at its factory in Wavre, Belgium, were not up to standard.
Britain's biggest drugmaker, whic
GlaxoSmithKline said European regulators had given the green light to its once-weekly diabetes drug albiglutide, which it is marketing as Eperzan.
Albiglutide belongs to the same class of injectable GLP-1 drugs as Victoza from Nov
An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in a major late-stage clinical study, dealing a blow to one of the company's biggest new treatment hopes.
China announced a nationwide crackdown on the sale of illegal medicine on Wednesday and said it would tighten industry regulation, piling pressure on a sector already reeling from a bribery scandal at British drugmaker GlaxoSmithKline.
Chinese police on Monday accused British drugmaker GlaxoSmithKline of channelling bribes to Chinese officials and doctors through travel agencies for six years to illegally boost sales and to raise the price of its medicines in the country.